SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Lilly Presents First Clinical Data for Investigational Ovarian Cancer Drug

Lilly presented clinical data for its investigational next-generation, folate receptor alpha-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer.

LLY

Related stories